Quelle est la capitalisation boursière pour Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318)

La capitalisation boursière pour Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318) est $612.03M

Bénéfices de Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318)

Q: Quel est le prix pour Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318)

Le prix pour Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318) est $0.74920478

Beijing Bohui Innovation Biotechnology Group Co., Ltd. is a Chinese enterprise that manages the full spectrum of diagnostic product operations, from initial research and development through manufacturing, sales, and post-sale support. Their offerings include a variety of diagnostic tools such as the GenPlex microfluidic automated system for nucleic acid detection, immunofluorescence detection solutions, and products for analyzing human trace elements. Additionally, the company provides advanced chemical analysis instrumentation, featuring atomic fluorescence spectrometers, photometers, mass spectrometers, chip ion sources, microfluidic flow chemical analysis systems, and ICP spectroscopy equipment, along with vital consumables for life sciences. Founded in 2001, the company is headquartered in Beijing, China. It adopted its current name, Beijing Bohui Innovation Biotechnology Group Co., Ltd., in August 2021, having previously been known as Beijing Bohui Innovation Biotechnology Co., Ltd.

Année	Bénéfices	Changez
Pas assez de données pour les dates fournies.

Année

Bénéfices

Changez

Pas assez de données pour les dates fournies.

Entreprise	Bénéfices	Différence de bénéfices	Pays
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
CSL Limited CSL.AX	$-4.02B	-	AU
Moderna, Inc. MRNA.US	$-3.09B	-	US
Lonza Group AG LONN.SW	-	-	CH

Entreprise

Bénéfices

Différence de bénéfices

Pays